Shanghai Xihua Scientific Co.,Ltd.

Shanghai Xihua Scientific Co.,Ltd. is a leading international biomedical technology entity company, epitomizing quality, punctuality, and preciseness. Founded in the China Pilot (Shanghai) Free Trade Zone in February 2015, it has rapidly expanded its operations, maintaining the highest quality standards in both China and the United States. With two locations in the Shanghai Zhang Jiang Pharm Valley spanning over 5,600 sq.m., and an affiliate, Primera Analytical Solutions Corp., in Princeton, New Jersey, Xihua has solidified its presence as a comprehensive solution provider in late phase drug research and development. With a commitment to excellence, Xihua offers a comprehensive suite of services for the global pharmaceutical industry, covering innovative and generic drug CMC, API process development, formulation development, analytical testing, bio-analytical, clinical trial services, and statistics. Additionally, it provides consultation and training in study and quality-related aspects. Notably, Xihua has secured considerable recognition within the industry, boasting a robust network of partnerships with over 100 clients, including pharmaceutical companies, hospital clinical units, clinical CROs, universities, and research institutes. The company's remarkable growth trajectory has been supplemented by a recent $2.94M Angel Round investment on 24 July 2018, with financial backing from Hidragon Capital, signifying growing investor confidence in their potential. With a visionary approach and a strong foundation, Shanghai Xihua Scientific Co.,Ltd. is well-positioned to make substantial contributions to the health care industry.